Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for ...

Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some medications showed adverse effects, ibuprofen, along with aspirin and ...

The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Background and objective: Nonsteroidal anti-inflammatory drugs are effective analgesics ... oxygenase type-2 inhibitor, with ibuprofen in the treatment of pain after tonsillectomy.

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been ...

The phase 2a trial showed rapid onset as well as long-lasting pain reduction with Algiax's allosteric GABAA-receptor modulator AP-325, setting up further trials of the drug. Neuropathic pain can ...

This bipartisan legislation would ensure that Medicare covers non-opioid pain medications, giving seniors access to safer treatment options without facing higher costs or hoops to jump through.

Animal-drug maker Zoetis is alerting dog owners and veterinarians to potential debilitating side effects from a new arthritis injection that have caused some dogs to be euthanized. The company ...

In the wake of this epidemic, drug developers have been searching tirelessly for non-addictive medicines that can combat pain without triggering the brain’s reward systems that contribute to the risk ...

The drug works via the same target as capsaicin, a compound found in chilli peppers that is used in some topical formulations for pain relief in arthritis and other conditions, but is much more ...

Aims: The use of medication in pain management currently involves empirical adjustment based on observed clinical outcome and the presence of adverse drug reactions. In this study ...

Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its oncology drug ... one of the dual primary endpoints of the study ...